Bluebird Bio | BLUE - Sales Revenues


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Bluebird Bio

Bluebird Bio reported $2.38M in Sales Revenues for its fiscal quarter ending in March of 2023.


Sales Change
Agios Pharmaceuticals AGIO:US USD 5.61M 1.3M
Alnylam Pharmaceuticals ALNY:US USD 319.29M 15.74M
Amgen AMGN:US USD 6.1B 734M
Arrowhead Research ARWR:US USD 146.27M 83.72M
Biogen BIIB:US USD 2.46B 81M
BioMarin Pharmaceutical BMRN:US USD 596.42M 58.88M
Bluebird Bio BLUE:US USD 2.38M 2.32M
Gilead Sciences GILD:US USD 6.35B 1.04B
Immunogen IMGN:US USD 49.87M 8.7M
Incyte Corp INCY:US USD 808.67M 118.03M
Intercept Pharmaceuticals ICPT:US USD 67.96M 9.26M
Ionis Pharmaceuticals IONS:US USD 130.52M 21.36M
Mirati Therapeutics MRTX:US USD 7.17M 6.23M
Moderna Inc MRNA:US USD 1.86B 3.22B
Nektar Therapeutics NKTR:US USD 21.59M 429K
Novartis NOVN:VX USD 13.21B 207M
Pfizer PFE:US USD 18.28B 6.01B
PTC Therapeutics PTCT:US USD 220.38M 52.97M
Regeneron Pharmaceuticals REGN:US USD 3.16B 252.3M
Sangamo BioSciences SGMO:US USD 157.96M 130.73M
Sarepta Therapeutics SRPT:US USD 253.5M 4.93M
Seattle Genetics SGEN:US USD 519.72M 8.43M
Ultragenyx Pharmaceutical RARE:US USD 100.5M 2.85M
Vertex Pharmaceuticals VRTX:US USD 2.37B 72.1M